Ho-Juhn Song

Ho-Juhn Song began their work experience as the CEO and Founder of PineTree Therapeutics Inc in January 2019. Prior to this, they worked at Novartis Institutes for BioMedical Research as a Project Team Leader from April 2004 to December 2008. Before that, they held the same role at Novartis AG starting in 2002 and ending in 2008.

Ho-Juhn Song completed their Ph.D. in Genetics/Neurosciences from Oregon State University, where they studied from 1994 to 2002.